Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-05-12

Clinical Trial Update: Can Enhanced Glycemic Control in Type II Diabetics Improve Myocardial Protection During Coronary Artery Bypass Grafting? [NA]

View source ↗

Summary

The document reports a clinical trial update evaluating whether enhanced glycemic control improves myocardial protection during coronary artery bypass grafting …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital Birmingham | Conditions: Type 2 Diabetes | NA | Status: UNKNOWN